Differences in beta-amyloid (beta/A4) deposition in human patients with Down's syndrome and sporadic Alzheimer's disease
- PMID: 8047269
- DOI: 10.1016/0304-3940(94)90374-3
Differences in beta-amyloid (beta/A4) deposition in human patients with Down's syndrome and sporadic Alzheimer's disease
Abstract
The density of diffuse, primitive, classic and compact beta-amyloid (beta/A4) deposits was estimated in the hippocampus and adjacent gyri in human patients with Down's syndrome (DS) and sporadic Alzheimer's disease (AD). The objective of the study was to determine whether there were differences in beta/A4 deposition in DS and sporadic AD and whether these differences could be attributed to overexpression of the amyloid precursor gene (APP) in DS. Total beta/A4 deposit density was greater in DS than AD in all brain regions studied but the DS/AD density ratios varied between brain regions. In the majority of brain regions, the ratio of primitive to diffuse beta/A4 deposits was greater in DS but the ratio of classic to diffuse deposits was greater in AD. The data were consistent with the hypothesis that overexpression of the APP gene in DS may lead to increased beta/A4 deposition. However, local brain factors also appear to be important in beta/A4 deposition in DS. Overexpression of the APP gene may also be responsible for increased production of paired helical filaments (PHF) and result in enhanced formation of primitive beta/A4 deposits in DS. In addition, increased formation of classic deposits in AD suggests that factors necessary for the production of a compact amyloid core are enhanced in AD compared with DS.
Similar articles
-
The spatial patterns of beta/A4 deposit subtypes in Down's syndrome.Acta Neuropathol. 1994;88(4):353-8. doi: 10.1007/BF00310379. Acta Neuropathol. 1994. PMID: 7839828
-
The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease.Acta Neuropathol. 1990;80(3):318-27. doi: 10.1007/BF00294651. Acta Neuropathol. 1990. PMID: 1698007
-
Beta-amyloid (beta/A4) deposition in the medial temporal lobe in Down's syndrome: effects of brain region and patient age.Neurobiol Dis. 1994 Dec;1(3):139-44. doi: 10.1006/nbdi.1994.0017. Neurobiol Dis. 1994. PMID: 9173993
-
Regulation and expression of the Alzheimer's beta/A4 amyloid protein precursor in health, disease, and Down's syndrome.Ann N Y Acad Sci. 1993 Sep 24;695:91-102. doi: 10.1111/j.1749-6632.1993.tb23035.x. Ann N Y Acad Sci. 1993. PMID: 8239320 Review.
-
Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.Am J Pathol. 1993 May;142(5):1449-57. Am J Pathol. 1993. PMID: 7684195 Free PMC article. Review.
Cited by
-
Comparative quantitative study of 'signature' pathological lesions in the hippocampus and adjacent gyri of 12 neurodegenerative disorders.J Neural Transm (Vienna). 2015 Oct;122(10):1355-67. doi: 10.1007/s00702-015-1402-8. Epub 2015 May 1. J Neural Transm (Vienna). 2015. PMID: 25929331
-
Transforming growth factor beta2 is a neuronal death-inducing ligand for amyloid-beta precursor protein.Mol Cell Biol. 2005 Nov;25(21):9304-17. doi: 10.1128/MCB.25.21.9304-9317.2005. Mol Cell Biol. 2005. PMID: 16227582 Free PMC article.
-
Age-related alteration of PKC, a key enzyme in memory processes: physiological and pathological examples.Mol Neurobiol. 1998 Feb;16(1):49-62. doi: 10.1007/BF02740602. Mol Neurobiol. 1998. PMID: 9554701 Review.
-
The struggle by Caenorhabditis elegans to maintain proteostasis during aging and disease.Biol Direct. 2016 Nov 3;11(1):58. doi: 10.1186/s13062-016-0161-2. Biol Direct. 2016. PMID: 27809888 Free PMC article. Review.
-
Mercury Reduces the Enzymatic Activity of Neprilysin in Differentiated SH-SY5Y Cells.Toxicol Sci. 2015 May;145(1):128-37. doi: 10.1093/toxsci/kfv037. Epub 2015 Feb 10. Toxicol Sci. 2015. PMID: 25673500 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
